Desensitization for drug hypersensitivity

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 3, 2008, Pages 581-582

  Adkinson Jr , N Franklin ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Desensitization; drug hypersensitivity

Indexed keywords

IMMUNOGLOBULIN E; PACLITAXEL; RITUXIMAB;

CANCER CHEMOTHERAPY; DESENSITIZATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HUMAN; PREMEDICATION; PRIORITY JOURNAL; SKIN TEST;

ANTINEOPLASTIC AGENTS; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMANS;

EID: 50649090277     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.07.020     Document Type: Editorial

References (9)

1. Castells M.C., Tennant N.M., Sloane D.E., Hsu F.I., Barrett N.A., Hong D.I., et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 122 (2008) 574-580
2. Lenz H.J. Management and preparedness for infusion and hypersensitivity reactions. Oncologist 12 (2007) 601-609
3. Chung C.H. Managing premedications and the risk for reactions to infusional monoclonal antibody therapy. Oncologist 13 (2008) 725-732
4. Lee C.W., Matulonis U.A., and Castells M.C. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol 95 (2004) 370-376
5. Naclerio R.M., Mizrahi E.A., and Adkinson Jr. N.F. Desensitization and maintenance of clinical tolerance to penicillin. J Allergy Clin Immunol 71 (1983) 294-301
6. Sehn L.H., Donaldson J., Filewich A., Fitzgerald C., Gill K.K., Runzer N., et al. Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting. Blood 109 (2007) 4171-4173
7. Ardavanis A., Tryfonopoulos D., Yiotis I., Gerasimidis G., Baziotis N., and Rigatos G. Non-allergic nature of docetaxel-induced acute hypersensitivity reactions. Anticancer Drugs 15 (2004) 581-585
8. Peereboom D.M., Donehower R.C., Eisenhauer E.A., McGuire W.P., Onetto N., Hubbard J.L., et al. Successful re-treatment with taxol after major hypersensitivity reactions. J Clin Oncol 11 (1993) 885-890
9. Meyer L., Zuberbier T., Worm M., and Oettle H. Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule. J Clin Oncol 20 (2002) 1146-1147